| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | -0.0092 | 0.8 |
| mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | BRD-K16130065 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | CEP-701 | GDSC1000 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.0078 | 0.8 |
| mRNA | bafilomycin A1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.8 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |